Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges.
about
Adverse events associated with testosterone administrationInfluence of age and sex steroids on bone density and geometry in middle-aged and elderly European men.Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteriaRisk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation.Turbulent flow chromatography in bioanalysis: a review.Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry.Steroid assays in paediatric endocrinology.Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetesReference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohortsClinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitationThe Minnesota Green Tea Trial (MGTT), a randomized controlled trial of the efficacy of green tea extract on biomarkers of breast cancer risk: study rationale, design, methods, and participant characteristics.Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring ImplicationsInsulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 DiabetesTestosterone concentrations in young pubertal and post-pubertal obese males.Key diagnostic finding in a condition with variable clinical presentations.Challenges and benefits of endogenous steroid analysis by LC-MS/MS.Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.LC-MS/MS in endocrinology: what is the profit of the last 5 years?Statistical methods used in the calculation of geriatric reference intervals: a systematic review.Current medical management of endocrine-related male infertility.Advances in bioanalytical techniques to measure steroid hormones in serum.Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe.Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes.A high-speed liquid chromatography/tandem mass spectrometry platform using multiplexed multiple-injection chromatography controlled by single software and its application in discovery ADME screening.Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS).Evaluating Calculated Free Testosterone as a Predictor of Morbidity and Mortality Independent of Testosterone for Cross-sectional and 5 year Longitudinal Health Outcomes in Older Men: The Concord Health and Ageing in Men Project.Relationship between depressive symptoms and hypogonadism in men with COPD.Testosterone does not affect agrin cleavage in mobility-limited older men despite improvement in physical function.Sexual dysfunction in men with COPD: impact on quality of life and survival.Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men.
P2860
Q24601802-19709D46-2023-4335-87B5-9E7031234463Q33739241-31C6DFEA-C063-47A8-9A44-8337E377E012Q34009160-0BA89475-8B88-4304-B68C-267B84A37D3FQ34259431-23BBD55F-3A23-4F19-929A-9185B608CFD2Q34317104-5B07FF57-DDEC-4EB1-9C0A-3FCA8FA48E8CQ34419912-5F3DA98A-AD69-4CBA-922E-4448495BDD33Q34423161-9811F06C-B67F-4544-8D4A-8A60B2E1D75CQ35123346-8E424D43-4FF5-49A8-B3D9-C69A5E5DD931Q35137175-1F017D6D-8DDB-4DF6-9BC1-EE72398F7D69Q35459531-412B4CAC-3755-47BB-85E4-A2B7E970168CQ36054249-69A4FAF7-AE7D-4897-887E-44E44A039E04Q36060464-3ADD15C6-5B85-4BB2-ACD8-994941FE1A60Q36392574-AC4FA85C-D83B-4C45-BF1C-B3DE7A4C8C1AQ36472816-C2C204F4-34D9-49C8-AE9D-4B23F9FF8214Q37107791-14B0BD18-35B9-4142-A523-B4A53ED88925Q37961970-6426ED91-693C-429B-88F1-546319630559Q38101855-FE7E29EF-4C45-487A-BEE1-408178E8E4FDQ38171546-A56E4E64-5C7D-452B-B720-10CED73628D0Q38583372-72FDDEE7-466F-4120-A301-71B8D40DC3C9Q38813302-C60F6F9D-489E-44E6-9828-BD0E9F3CFF34Q38842710-6592646B-ABA4-40B4-AACD-7CCC5E64045DQ38890081-9A70144F-5C5C-49C0-8FFF-A91FF3427846Q42494574-C1A5587A-9367-41C8-BE5F-9736FB11E93AQ42692020-CCEB3363-1BDD-4D8B-8C2E-D0491A8CDBBBQ47130237-C0A1D9BA-E310-41AA-B287-1BA4FDD3AEA1Q47668257-5BDB5AC2-F7E7-4B6C-86FB-42A86F310754Q48122641-7B8CC99E-51E2-4284-8329-021878CAF214Q48285528-C81A8F60-F6ED-4975-9C62-E42C855CE362Q48421412-DA4EE564-FE8D-482C-893F-FA071ED5E27EQ49764027-E2FB6E92-3D54-401B-BB15-54E09B952D5A
P2860
Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Validation of a total testoste ...... testosterone reference ranges.
@ast
Validation of a total testoste ...... testosterone reference ranges.
@en
type
label
Validation of a total testoste ...... testosterone reference ranges.
@ast
Validation of a total testoste ...... testosterone reference ranges.
@en
prefLabel
Validation of a total testoste ...... testosterone reference ranges.
@ast
Validation of a total testoste ...... testosterone reference ranges.
@en
P2093
P1433
P1476
Validation of a total testoste ...... testosterone reference ranges.
@en
P2093
Michael P Caulfield
Mildred M Redor-Goldman
Nigel J Clarke
Richard E Reitz
P304
P356
10.1016/J.STEROIDS.2009.11.004
P577
2009-11-17T00:00:00Z